Chambers C, Watakul S, Schofield P, Howell A, Zhu J, Tran A
Sci Adv. 2025; 11(11):eadq4416.
PMID: 40073121
PMC: 11900870.
DOI: 10.1126/sciadv.adq4416.
Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C
Signal Transduct Target Ther. 2025; 10(1):39.
PMID: 39948335
PMC: 11825823.
DOI: 10.1038/s41392-024-02098-3.
Wu A, Liu F, Zhou L, Jiang R, Yu S, Zhou Z
Discov Oncol. 2024; 15(1):848.
PMID: 39738986
PMC: 11685356.
DOI: 10.1007/s12672-024-01689-4.
Dahan M, Zohar J, Todder D, Mathe A, Cohen H
Int J Neuropsychopharmacol. 2024; 27(12).
PMID: 39626016
PMC: 11653009.
DOI: 10.1093/ijnp/pyae062.
Yamaguchi M, Noda-Asano S, Inoue R, Himeno T, Motegi M, Hayami T
Int J Mol Sci. 2024; 25(16).
PMID: 39201570
PMC: 11354620.
DOI: 10.3390/ijms25168881.
Improved Chemical and Radiochemical Synthesis of Neuropeptide Y Y Receptor Antagonist -Methyl-JNJ-31020028 and Preclinical Positron Emission Tomography Studies.
Fonseca I, Pais M, Rodrigues F, Sereno J, Castelo-Branco M, Cavadas C
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675435
PMC: 11053772.
DOI: 10.3390/ph17040474.
Novel enzyme-resistant pancreatic polypeptide analogs evoke pancreatic beta-cell rest, enhance islet cell turnover, and inhibit food intake in mice.
Zhu W, Tanday N, Lafferty R, Flatt P, Irwin N
Biofactors. 2024; 50(6):1101-1112.
PMID: 38635341
PMC: 11627468.
DOI: 10.1002/biof.2059.
Illuminating Neuropeptide Y Y Receptor Binding: Fluorescent Cyclic Peptides with Subnanomolar Binding Affinity as Novel Molecular Tools.
Gleixner J, Kopanchuk S, Gratz L, Tahk M, Laasfeld T, Veiksina S
ACS Pharmacol Transl Sci. 2024; 7(4):1142-1168.
PMID: 38633582
PMC: 11019746.
DOI: 10.1021/acsptsci.4c00013.
Neural basis for fasting activation of the hypothalamic-pituitary-adrenal axis.
Douglass A, Resch J, Madara J, Kucukdereli H, Yizhar O, Grama A
Nature. 2023; 620(7972):154-162.
PMID: 37495689
PMC: 11168300.
DOI: 10.1038/s41586-023-06358-0.
Biomolecular Markers of Brain Aging.
Li M, An H, Wang W, Wei D
Adv Exp Med Biol. 2023; 1419:111-126.
PMID: 37418210
DOI: 10.1007/978-981-99-1627-6_9.
Neuropeptide Y and melanocortin receptors in fish: regulators of energy homeostasis.
Hou Z, Wen H
Mar Life Sci Technol. 2023; 4(1):42-51.
PMID: 37073356
PMC: 10077275.
DOI: 10.1007/s42995-021-00106-x.
Protective Role and Functional Engineering of Neuropeptides in Depression and Anxiety: An Overview.
Okdeh N, Mahfouz G, Harb J, Sabatier J, Roufayel R, Gazo Hanna E
Bioengineering (Basel). 2023; 10(2).
PMID: 36829752
PMC: 9952193.
DOI: 10.3390/bioengineering10020258.
The PYY/Y2R-deficient male mouse is not protected from bone loss due to Roux-en-Y gastric bypass.
Zahedi B, Daley E, Brooks D, Bruce M, Townsend R, Berthoud H
Bone. 2022; 167:116608.
PMID: 36368466
PMC: 10064867.
DOI: 10.1016/j.bone.2022.116608.
Immunomodulatory Role of Neuropeptides in the Cornea.
Puri S, Kenyon B, Hamrah P
Biomedicines. 2022; 10(8).
PMID: 36009532
PMC: 9406019.
DOI: 10.3390/biomedicines10081985.
Supplementing Flavonoid Extract in High-Fat Finishing Diets Improves Animal Behavior and Rumen Health and Modifies Rumen and Duodenum Epithelium Gene Expression in Holstein Bulls.
Paniagua M, Crespo J, Aris A, Devant M
Animals (Basel). 2022; 12(15).
PMID: 35953962
PMC: 9367586.
DOI: 10.3390/ani12151972.
PET Imaging of the Neuropeptide Y System: A Systematic Review.
Fonseca I, Castelo-Branco M, Cavadas C, Abrunhosa A
Molecules. 2022; 27(12).
PMID: 35744852
PMC: 9227365.
DOI: 10.3390/molecules27123726.
Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors.
Tang T, Tan Q, Han S, Diemar A, Lobner K, Wang H
Sci Adv. 2022; 8(18):eabm1232.
PMID: 35507650
PMC: 9067930.
DOI: 10.1126/sciadv.abm1232.
Avian Neuropeptide Y: Beyond Feed Intake Regulation.
Greene E, Abdelli N, Dridi J, Dridi S
Vet Sci. 2022; 9(4).
PMID: 35448669
PMC: 9028514.
DOI: 10.3390/vetsci9040171.
Structural basis of neuropeptide Y signaling through Y1 receptor.
Park C, Kim J, Ko S, Choi Y, Jeong H, Woo H
Nat Commun. 2022; 13(1):853.
PMID: 35165283
PMC: 8844075.
DOI: 10.1038/s41467-022-28510-6.
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment.
Wilson J, Garner E, Mashayekhi M, Hubers S, Ramirez Bustamante C, Kerman S
Hypertension. 2022; 79(4):827-835.
PMID: 35045722
PMC: 8917054.
DOI: 10.1161/HYPERTENSIONAHA.121.18348.
